Using RT-PCR the authors proved that selected gliomas express ADAMTS4 and -5 when grown in situ, while GBM samples demonstrated the highest expression of these proteins, implicating these factors in malignancy [61]. The gene discussed is ADAMTS4; the disease is central nervous system cancer.